Following peripheral (sciatic) nerve injury, Phd3−/− mice demonstrated increased axonal regeneration and reduced cold hyperalgesia, indicating that pharmaceutical PHD3 inhibition may be a treatment option for peripheral nerve injury [139]. This evidence concerns the gene EGLN3 and peripheral nerve injury.